Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Matthijs Boekholdt

Showing results (1-10 of 271) with videos related to

Pageof 28
Sort By:
Current Opinion in Cardiology|September 21, 2010
Should we change our lipid management strategies to focus on non-high-density lipoprotein cholesterol?Jamal S Rana, S Matthijs Boekholdt
Current Atherosclerosis Reports|November 26, 2013
Clinical and biological relevance of statin-mediated changes in HDL metabolismBenoit J Arsenault, S Matthijs Boekholdt
Journal of Lipid Research|March 18, 2003
Natural genetic variation as a tool in understanding the role of CETP in lipid levels and diseaseS Matthijs Boekholdt, John F Thompson
The Canadian Journal of Cardiology|December 31, 2016
An Evidence-Based Guide to Cholesterol-Lowering GuidelinesDavid D Waters, S Matthijs Boekholdt
Expert Review of Cardiovascular Therapy|July 31, 2010
Improving risk stratification for cardiovascular diseaseDiederik F van Wijk, S Matthijs Boekholdt
Lancet (London, England)|December 25, 2009
C-reactive protein and cardiovascular risk: more fuel to the fireS Matthijs Boekholdt, John J P Kastelein
The New England Journal of Medicine|December 13, 2002
Gene polymorphisms and the risk of myocardial infarction--an emerging relationRon J G Peters, S Matthijs Boekholdt
Seminars in Thrombosis and Hemostasis|September 5, 2007
Arterial thrombosis and the role of thrombophiliaS Matthijs Boekholdt, Mark H H Kramer
Lancet (London, England)|August 17, 2010
Rimonabant: obituary for a wonder drugS Matthijs Boekholdt, Ron J G Peters
Lancet (London, England)|March 17, 2012
The interleukin-6 pathway and atherosclerosisS Matthijs Boekholdt, Erik S G Stroes
Pageof 28

Showing results (1-10 of 271) with videos related to

Sort By:
Pageof 28
Current Opinion in Cardiology|September 21, 2010
Should we change our lipid management strategies to focus on non-high-density lipoprotein cholesterol?Jamal S Rana, S Matthijs Boekholdt
Current Atherosclerosis Reports|November 26, 2013
Clinical and biological relevance of statin-mediated changes in HDL metabolismBenoit J Arsenault, S Matthijs Boekholdt
Journal of Lipid Research|March 18, 2003
Natural genetic variation as a tool in understanding the role of CETP in lipid levels and diseaseS Matthijs Boekholdt, John F Thompson
The Canadian Journal of Cardiology|December 31, 2016
An Evidence-Based Guide to Cholesterol-Lowering GuidelinesDavid D Waters, S Matthijs Boekholdt
Expert Review of Cardiovascular Therapy|July 31, 2010
Improving risk stratification for cardiovascular diseaseDiederik F van Wijk, S Matthijs Boekholdt
Lancet (London, England)|December 25, 2009
C-reactive protein and cardiovascular risk: more fuel to the fireS Matthijs Boekholdt, John J P Kastelein
The New England Journal of Medicine|December 13, 2002
Gene polymorphisms and the risk of myocardial infarction--an emerging relationRon J G Peters, S Matthijs Boekholdt
Seminars in Thrombosis and Hemostasis|September 5, 2007
Arterial thrombosis and the role of thrombophiliaS Matthijs Boekholdt, Mark H H Kramer
Lancet (London, England)|August 17, 2010
Rimonabant: obituary for a wonder drugS Matthijs Boekholdt, Ron J G Peters
Lancet (London, England)|March 17, 2012
The interleukin-6 pathway and atherosclerosisS Matthijs Boekholdt, Erik S G Stroes
Pageof 28